Clinical Trials Directory

Trials / Terminated

TerminatedNCT00384995

Bicarbonate v Saline to Prevent Contrast Nephropathy

Phase 4 Study of Bicarbonate Versus Saline Infusion Therapy to Prevent Contrast Induced Nephropathy (CAN-IT PREVENT Protocol)

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Italian Society of Nephrology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Slowing of kidney function occurs in a minority of people given dye during angiography. The purpose of this study is to compare two different types of fluid given into a vein to reduce the risk of kidney injury: salt in water or baking soda in water.

Detailed description

A decline in kidney function after contrast is associated with prolonged hospital stay, adverse cardiac events, and higher mortality both in hospital and in the long term. Deliberate administration of fluids is recommended to reduce the risk of contrast nephropathy. However, data to support specific recommendations are lacking and the optimal fluid regimen remains unclear. It has been hypothesized that alkalinization of tubular fluid might be beneficial by reducing pH dependent free radical levels. A recent trial found a lower frequency of creatinine rise \> 25% within two days of contrast with a 7 hour infusion of isotonic sodium bicarbonate than with saline infusion (Merten GJ, JAMA 2004). However, it remains to be proven that bicarbonate is superior as this trial has a number of methodological flaws. Comparison: IV 1/6 M sodium bicarbonate OR IV 0.9% saline, each isotonic fluid given at the same rate of sodium administration (3.25 ml/Kg over 1 hour pre-contrast, followed by 1.1 ml/Kg/hr for 6 hours for bicarbonate; 3.5 ml/Kg over 1 hour pre-contrast, followed by 1.2 ml/Kg/hr for 6 hours for saline). Total infusion time 7 hours (for both). Maximum rate of fluid permitted is that for a body weight of 110 Kg. Intra-vascular iso- or low-osmolality contrast in the minimal dose needed to complete the required imaging.

Conditions

Interventions

TypeNameDescription
DRUG0.9% (154 mEq/L) IV Sodium ChlorideSaline solution
DRUG1/6 M (166 mEq/L) IV Sodium BicarbonateBicarbonate solution

Timeline

Start date
2006-12-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2006-10-06
Last updated
2010-12-01

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT00384995. Inclusion in this directory is not an endorsement.